Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features.

Vatrano S, Giorcelli J, Votta A, Capone G, Izzo S, Gatti G, Righi L, Napoli F, Scagliotti G, Papotti M, Volante M, Rapa I.

Neuroendocrinology. 2020;110(1-2):1-9. doi: 10.1159/000500158. Epub 2019 Jun 12.

PMID:
31280263
2.

Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.

Zannoni GF, Santoro A, Angelico G, Spadola S, Arciuolo D, Valente M, Inzani F, Pettinato A, Vatrano S, Fanfani F, Scambia G, Fraggetta F.

Hum Pathol. 2019 Oct;92:10-17. doi: 10.1016/j.humpath.2019.06.005. Epub 2019 Jun 30.

PMID:
31269413
3.

Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for Unexpected "Vertigo".

Piermattei A, Santoro A, Angelico G, Inzani F, Valente M, Pettinato A, Vatrano S, Scambia G, Fraggetta F, Zannoni GF.

Int J Gynecol Pathol. 2020 Jan;39(1):68-71. doi: 10.1097/PGP.0000000000000550.

PMID:
30252727
4.

High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

Rapa I, Votta A, Gatti G, Izzo S, Buono NL, Giorgio E, Vatrano S, Napoli F, Scarpa A, Scagliotti G, Papotti M, Volante M.

Oncotarget. 2018 Jun 8;9(44):27535-27546. doi: 10.18632/oncotarget.25541. eCollection 2018 Jun 8.

5.

Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.

Improta G, Pettinato A, Høgdall E, Santeusanio G, Vatrano S, Fraggetta F, Zannoni GF.

Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):631-636. doi: 10.1097/PAI.0000000000000662.

PMID:
29629954
6.

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas.

Vatrano S, Volante M, Duregon E, Giorcelli J, Izzo S, Rapa I, Votta A, Germano A, Scagliotti G, Berruti A, Terzolo M, Papotti AM.

Mod Pathol. 2018 Aug;31(8):1257-1269. doi: 10.1038/s41379-018-0042-6. Epub 2018 Mar 26.

7.

Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.

Conti L, Vatrano S, Bertero L, Masu L, Pacchioni D, Daniele L, De Rosa G, Cassoni P, Volante M, Papotti M.

Hum Pathol. 2017 Nov;69:23-30. doi: 10.1016/j.humpath.2017.09.004. Epub 2017 Sep 27.

PMID:
28962946
8.

Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia.

Duregon E, Volante M, Guzzetti S, Rapa I, Vatrano S, Papotti M.

Endocr Pathol. 2017 Sep;28(3):276-279. doi: 10.1007/s12022-017-9480-9. No abstract available.

PMID:
28382483
9.

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.

Righi L, Duregon E, Vatrano S, Izzo S, Giorcelli J, Rondón-Lagos M, Ascoli V, Ruffini E, Ventura L, Volante M, Papotti M, Scagliotti GV.

J Thorac Oncol. 2016 Nov;11(11):2006-2017. doi: 10.1016/j.jtho.2016.06.020. Epub 2016 Jul 13.

10.

Mesothelioma families without inheritance of a BAP1 predisposing mutation.

Ascoli V, Cozzi I, Vatrano S, Izzo S, Giorcelli J, Romeo E, Carnovale-Scalzo C, Grillo LR, Facciolo F, Visca P, Papotti M, Righi L.

Cancer Genet. 2016 Sep;209(9):381-387. doi: 10.1016/j.cancergen.2016.07.002. Epub 2016 Jul 18.

11.

Androgen deprivation modulates gene expression profile along prostate cancer progression.

Volante M, Tota D, Giorcelli J, Bollito E, Napoli F, Vatrano S, Buttigliero C, Molinaro L, Gontero P, Porpiglia F, Tucci M, Papotti M, Berruti A, Rapa I.

Hum Pathol. 2016 Oct;56:81-8. doi: 10.1016/j.humpath.2016.06.004. Epub 2016 Jun 21.

PMID:
27342909
12.

Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.

Giunchi F, Fiorentino M, Vagnoni V, Capizzi E, Bertolo R, Porpiglia F, Vatrano S, Tamberi S, Schiavina R, Papotti M, Bollito E.

Pathology. 2016 Jan;48(1):41-6. doi: 10.1016/j.pathol.2015.11.009. Epub 2015 Dec 18.

13.

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.

Righi L, Vatrano S, Di Nicolantonio F, Massa F, Rossi G, Cavazza A, Volante M, Votta A, Izzo S, Lo Iacono M, Ardissone F, Di Maio M, Novello S, Scagliotti GV, Papotti M.

J Thorac Oncol. 2016 Apr;11(4):504-15. doi: 10.1016/j.jtho.2016.01.004. Epub 2016 Jan 13.

14.

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study.

Vatrano S, Righi L, Vavalá T, Rapa I, Busso M, Izzo S, Cappia S, Veltri A, Papotti M, Scagliotti GV, Novello S.

Target Oncol. 2016 Apr;11(2):157-66. doi: 10.1007/s11523-015-0383-8.

15.

Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.

Duregon E, Volante M, Rapa I, Vatrano S, Papotti M.

Turk Patoloji Derg. 2015;31 Suppl 1:98-104. doi: 10.5146/tjpath.2015.01317. Review.

16.

EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer.

Malapelle U, Vatrano S, Russo S, Bellevicine C, de Luca C, Sgariglia R, Rocco D, de Pietro L, Riccardi F, Gobbini E, Righi L, Troncone G.

J Clin Pathol. 2015 Sep;68(9):739-41. doi: 10.1136/jclinpath-2015-203101. Epub 2015 Jun 5.

PMID:
26047622
17.

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome.

Righi L, Vavalà T, Rapa I, Vatrano S, Giorcelli J, Rossi G, Capelletto E, Novello S, Scagliotti GV, Papotti M.

J Thorac Oncol. 2014 Oct;9(10):1540-6. doi: 10.1097/JTO.0000000000000271.

18.

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

Lo Iacono M, Monica V, Righi L, Grosso F, Libener R, Vatrano S, Bironzo P, Novello S, Musmeci L, Volante M, Papotti M, Scagliotti GV.

J Thorac Oncol. 2015 Mar;10(3):492-9. doi: 10.1097/JTO.0000000000000436.

19.

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.

Ricci MT, Menegon S, Vatrano S, Mandrile G, Cerrato N, Carvalho P, De Marchi M, Gaita F, Giustetto C, Giachino DF.

Sci Rep. 2014 Sep 25;4:6470. doi: 10.1038/srep06470.

20.

Therapeutic biomarkers in lung neuroendocrine neoplasia.

Righi L, Volante M, Rapa I, Vatrano S, Pelosi G, Papotti M.

Endocr Pathol. 2014 Dec;25(4):371-7. doi: 10.1007/s12022-014-9335-6. Review.

21.

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.

Betti M, Casalone E, Ferrante D, Romanelli A, Grosso F, Guarrera S, Righi L, Vatrano S, Pelosi G, Libener R, Mirabelli D, Boldorini R, Casadio C, Papotti M, Matullo G, Magnani C, Dianzani I.

Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.

PMID:
25231345
22.

Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis.

Mazibrada J, Longo L, Vatrano S, Cappia S, Giorcelli J, Pentenero M, Gandolfo S, Volante M, dell'Oste V, Lo Cigno I, Biolatti M, Landolfo S, Papotti M.

New Microbiol. 2014 Apr;37(2):129-43. Epub 2014 Apr 1.

23.

H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.

Oudijk L, de Krijger RR, Rapa I, Beuschlein F, de Cubas AA, Dei Tos AP, Dinjens WN, Korpershoek E, Mancikova V, Mannelli M, Papotti M, Vatrano S, Robledo M, Volante M.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1376-80. doi: 10.1210/jc.2013-3879. Epub 2014 Mar 31.

24.

Natural history of vertically acquired HCV infection and associated autoimmune phenomena.

Garazzino S, Calitri C, Versace A, Alfarano A, Scolfaro C, Bertaina C, Vatrano S, Mignone F, Licciardi F, Gabiano C, Tovo PA.

Eur J Pediatr. 2014 Aug;173(8):1025-31. doi: 10.1007/s00431-014-2286-6. Epub 2014 Mar 4.

PMID:
24585099
25.

Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.

Righi L, Cuccurullo A, Vatrano S, Cappia S, Giachino D, De Giuli P, Ardine M, Novello S, Volante M, Scagliotti GV, Papotti M.

BMC Cancer. 2013 Mar 13;13:114. doi: 10.1186/1471-2407-13-114.

26.

Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy.

Coppo R, Camilla R, Amore A, Peruzzi L, Daprà V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T, Dal Canton A.

Clin Exp Immunol. 2010 Jan;159(1):73-81. doi: 10.1111/j.1365-2249.2009.04045.x. Epub 2009 Nov 5. Erratum in: Clin Exp Immunol. 2010 Mar;159(3):372. Clin Exp Immunol. 2010 May;160(2):293.

Supplemental Content

Loading ...
Support Center